Red Flags Detected

• ⚠ Delisting (new) — Nasdaq formally notified company of minimum bid price violation; failure to cure by September 16, 2026 triggers delisting and potential debt defaults.
• ⚠ Business Pivot (new) — Complete abandonment of biomedical business for speculative AI/quantum drone technology with zero operating history or proven revenue model.
• ⚠ Dilution Overhang (new) — Outstanding preferred shares convertible into 477M ordinary shares represent 2,000%+ potential dilution versus current 22.8M share base.